2021 International HBV Meeting
26-30 September 2021
Toronto, Hybrid event
ENYO Pharma team will be present at this event organized by The Hepatitis B Foundation.
https://www.hbvmeeting.org/r
Read next in 'Events'
- The 2024 international workshop on Alport syndrome
- ENYO Pharma annonce un financement de Série C de 39 millions d'euros et l’autorisation de la FDA (IND) pour tester Vonafexor dans un essai clinique de Phase 2 pour les patients atteints du syndrome d'Alport
- 6th CKD Summit – Chronic Kidney Disease Drug Development
- ASN Kidney Week
- Alport Connect 2023, the annual Alport syndrome patient and family meeting in US